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Purpose or Objective: In MRI guided radiotherapy (e.g. MR-
linac), radiation is delivered in presence of a magnetic field. 
Therefore, the dose deposition is different since the path of 
the secondary electrons is changed due to the Lorentz force. 
Especially at air-tissue interfaces this causes changes in dose 
distribution. An example is the change in reading of a 
ionization chamber in a magnetic field. Besides, since the 
electrons are bend, the net effect is that electrons will travel 
less in forward direction, as a result the local dose deposition 
will change slightly even in an area with homogenous density. 
How to account for these changes in the various codes of 
practice for reference dosimetry is yet under debate. The 
purpose of this abstract is to quantify the change in dose-to-
water (for a fixed setup) when applying a magnetic field. 
 
Material and Methods: The Monte Carlo (MC) dose engine 
from Monaco TPS (Elekta) was used to estimate the change in 
dose-to-water. Validation of this MC code against other 
established MC codes has been performed by other research 
groups. For different square field sizes (from 5 to 30 cm) the 
dose deposition of a 6MV photon beam of an Elekta Agility 
linac is calculated in a water phantom of 50x50x40 cm3 (SAD 
= 100 cm, SSD = 90 cm). Calculations were performed with 
and without a transversal 1.5T magnetic field for the same 
number of MU. MC variance was 0.1%. Difference in dose was 
calculated by means of the percentage difference in depth 
dose in a volumetric region below dose maximum and above 
phantom bottom (5<depth<35 cm) and around the central 
axis. A histogram of the percentage differences was 
calculated for all field sizes. Subsequently, a Gaussian 
function is fitted to the peak region of the histogram (central 
part) to reduce the binning effects. 
 
Results: In figure (a) an example of a depth dose curve (and 
close up) with and without magnetic field is shown for field 
size 10x10 cm2. Figure (b) shows the percentage difference 
for all square field sizes (9 sample point per field size). The 
mean percentage difference for all field sizes ranges 
between -0.4% and 0.55%. 
 
 
These results show, within the MC variance, that a tendency 
is visible over the different field sizes. This may be caused by 
the change in phantom scatter for different field sizes. 
However, the MC variation causes large variation in the ratio. 
For small field sizes (<5x5 cm2) penumbra effects will come 
into play and are for that reason disregarded. The effect of 
beam hardening is neglected in this work.  
 
Conclusion: A difference in dose-to-water can be estimated 
as -0.45% for a 10x10 cm2 field, which is related to the fact 
that the electrons travel less in forward direction. Note that 
this dose difference can also be expressed as a shift in PDD 
(in the order of a mm). Depending on the used code of 
practice for reference dosimetry, this difference needs to be 
taken into account when applying correction factors for 
magnetic field effects. 
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Purpose or Objective: Time-efficient dose delivery by 
volumetric modulated arc therapy (VMAT) for stereotactic 
body radiation therapy (SBRT) is gaining more and more 
interest in radiation oncology. The combination of VMAT with 
potentially-lethal SBRT doses in heterogeneous tissue 
circumstances has led to an emerging use of anthropomorphic 
phantoms for quality assurance (QA) of both therapeutic 
target dose coverage and organ-at-risk (OAR) sparing. In this 
study, the first evaluation worldwide of a new-generation 
anthropomorphic phantom (E2E SBRT phantom model 036A 
CIRS INC., Norfolk, VA) was conducted for dose delivery of 
spine and lung SBRT using VMAT. 
 
Material and Methods: The phantom mimics the thorax 
anatomy with lung-tissue surrounded by rib structures and 
vertebrae, allowing appropriate image-guidance with a 
subsequent anthropomorphic dose evaluation. The phantom 
was customized to fit an Exradin A1SL (Standard Imaging, 
Middleton, WI) ionization chamber (IC) in the tumor centroid 
and in the peripheral lung. Also TLD or alanine pellets 
cutouts are foreseen in the phantom. In thoracic and pelvic 
part of the phantom, both an axial and coronal plane are 
available for comparing calculated and measured film dose in 
the target area. A lung insert with a kidney-shaped tumor 
was specifically developed to verify VMAT lung SBRT with film 
and IC. The kidney-shaped lung tumor also allowed for a dose 
film evaluation of the isodose levels along both the medial 
concave and lateral convex border of the tumor. External 
markings on the insert allowed to simulate the influence of a 
rotational tumor offset (step size 1°) with respect to the 
planning CT. 
 
Results: To already illustrate the potential of the phantom, 
initial QA results obtained from the new phantom for a spine 
SBRT and a lung lesion with VMAT SBRT were visualized in 
Figure 1A and 1B. Overall, a good agreement was found 
between dose calculation of the treatment planning system 
and respectively film (>88%) (absolute dose) and IC (<3%) 
measurements. The difference in agreement score for an OAR 
close to respectively the concave or convex border of the 
tumor was similar (see Figure 1B). With 2 and 5 mm PTV 
margins for respectively spine and lung SBRT, up to 1° and 3° 
rotation of the phantom insert led to an adequate target 
coverage. 
 
S702                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
 
 
Conclusion: A novel, next-generation anthropomorphic 
phantom allows a versatile SBRT QA, by assessing high dose 
target coverage and simultaneous OAR dose or peripheral 
lung dose in an end-to-end testing setup hereby including 
inter-fraction rotations. The phantom will be the basis of a 
multi-center peer-to-peer institutional audit of thoracic 
IMRT/VMAT and SBRT. 
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Purpose or Objective: Stereotactic radiotherapy requires 
detectors capable of determining the delivered dose with 
high accuracy. The aim of this study is to characterize the 
performance of a new unshielded silicon diode prototype, the 
IBA Razor, for dose measurements in small radiation therapy 
photon beams in flattening filter free (FFF) mode 
 
Material and Methods: The performance of the newly 
commercialized stereotactic diode was evaluated relative to 
that of the previously available SFD diode and the PFD 
detectors, both from IBA. The Razor is made with an n-type 
implant in p-type silicon. The active volume is 0.6mm in 
diameter and 20µm in length. The detector response stability 
in measured dose, dose rate and dose per pulse were 
evaluated. Dark current as function of the received dose was 
also evaluated. The detector response in square fields, in the 
range from 0.8 to 5.0 cm, was evaluated by means of 
percentage depth dose curves (PDDs), axial beam profiles and 
output factors. 
 
Results: The short term stability of the Razor was found to 
be much improved relative to the SFD, exhibiting a variation 
of less than ±0.1% for a dose of 1.2 kGy delivered in a single-
session. Dose linearity showed a deviation of less than ±1% in 
the 0.05–30 Gy range and a dose rate dependence of less than 
±0.5% in the 4–24 Gy/min range. The dose per pulse 
dependence, evaluated in the 0.08-0.21 cGy/pulse range, 
was found to be within ±0.8%. A larger dark current with 
increase in dose was observed for the Razor with values of 
0.0025pA/Gy compared to the 0.0002pA/Gy for the SFD. This 
characteristic is attributed to an increased concentration of 
the recombination centers and can be practically solved by 
resetting the background before every acquisition.  
The measured PDDs agreed to within 1% with those obtained 
using the PFD detector. The profile analysis showed good 
results as long as a background correction was applied before 
each profile acquisition: penumbra differences were below 
±0.3 mm relative to PFD, with a slight overestimation of the 
tails (<1%), due to the absence of the shielding. When 
background correction was not applied regularly, larger 
differences were observed in the low dose penumbra region 
and in the profile tails, probably due to the higher dark 
current. Output factors were in good agreement with those 
measured by the PFD detector to within 1% for fields up to 
5x5 cm2, for larger fields the absence of the shielding in the 
stereotactic detector led to differences >2%. 
 
Conclusion: The new IBA Razor unshielded diode replaces the 
IBA SFD, with the additional advantages of improved stability 
(up to 1.2 kGy) compared to the reference stereotactic 
diode. The Razor has the same high spatial resolution and 
performance in small radiation fields. These features make 
the Razor diode detector a good candidate for radiation 
therapy and in small field dosimetry to support advanced 
radiation therapy techniques. 
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Purpose or Objective: In this study, a delivery quality 
assurance (DQA) method was designed to overcome the 
limitations of the conventional DQA process in the static 
condition for internal target volume (ITV)-based VMAT. The 
dynamic DQA measurement device was designed with a 
moving phantom that can simulate variable target motions. 
The dose distribution in the real volume of the target and 
OARs were reconstructed with the measurement data under 
the dynamic condition. Then, to evaluate the designed DQA 
method, the dose-volume histogram (DVH) data of the real 
target and OARs were compared with the DVHs calculated in 
the ITV-based VMAT plan. 
 
Material and Methods: The dynamic DQA measurement 
device was designed with a moving phantom that can 
simulate variable target motions. The dose distribution in the 
real volume of the target and organ-at-risk (OAR)s were 
reconstructed using 3DVH with the ArcCHECK measurement 
data under the dynamic condition. A total of 10 ITV-based 
RapidArc plans for liver-cancer patients were analyzed with 
